prostate-specific antigen | sciencenewsnet.in

Breaking News

Nonmotor Seizures May Be Missed in Children, Teens

CHOP Researchers Identify Causal Genetic Variant Linked to Common Childhood Obesity

Study: Hillocks challenge our understanding of lung biology

Register for Food and Nutrition Institute’s Fourth Annual Conference on Science, Regulation

Mayo Clinic Laboratories and Progentec Diagnostics launch lupus advanced biomarker testing services

May is Mental Health Awareness Month

Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute

Plant-LncPipe: a new tool for plant long non-coding RNA (lncRNA) identification

New findings point to an Earth-like environment on ancient Mars

At the Climate READi workshop: Resilient power systems in the context of climate change

01 May, 2024

Falling PSA levels predict longer survival in prostate cancer patients at high risk of metastases

February 10, 2023 sarah JonasResearch Results

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic castration-resistant prostate cancer (nmCRPC), reports The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.